Viewing Study NCT05817435


Ignite Creation Date: 2025-12-24 @ 10:41 PM
Ignite Modification Date: 2025-12-28 @ 6:25 AM
Study NCT ID: NCT05817435
Status: COMPLETED
Last Update Posted: 2023-10-31
First Post: 2023-04-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Bioequivalence Study of Efgartigimod PH20 SC Administered Via a Prefilled Syringe Versus a Vial+Syringe Presentation in Healthy Adults
Sponsor: argenx
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module